D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Neuroscience D-index 107 Citations 36,470 329 World Ranking 346 National Ranking 212
Medicine D-index 111 Citations 39,790 350 World Ranking 3124 National Ranking 1780

Research.com Recognitions

Awards & Achievements

2013 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Internal medicine
  • Neuron

His main research concerns Neuroscience, Striatum, Dopaminergic, Transplantation and Dopamine. His Neuroscience research is multidisciplinary, relying on both Neurotoxin, Neurodegeneration, Immunology and Nerve growth factor. His studies deal with areas such as Substantia nigra, Immunostaining and Anatomy as well as Striatum.

Ole Isacson is investigating Endocrinology and Internal medicine as part of his examination of Dopaminergic. His Transplantation research incorporates elements of Embryonic stem cell, Immunosuppression, Neuron and Pathology. Ole Isacson interconnects Neuroinflammation, Parkinson's disease and Midbrain in the investigation of issues within Dopamine.

His most cited work include:

  • Parkinson’s Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors (1366 citations)
  • Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model (1130 citations)
  • Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease (1065 citations)

What are the main themes of his work throughout his whole career to date?

Ole Isacson focuses on Neuroscience, Transplantation, Dopamine, Internal medicine and Parkinson's disease. His Neuroscience study combines topics in areas such as Embryonic stem cell, Disease and Stem cell. His Transplantation research includes themes of Fetal Tissue Transplantation, Immunology and Pathology.

He has researched Dopamine in several fields, including Pharmacology, Neuron and Midbrain. His work focuses on many connections between Internal medicine and other disciplines, such as Endocrinology, that overlap with his field of interest in Glutamate receptor and Nerve growth factor. The various areas that Ole Isacson examines in his Parkinson's disease study include Glucocerebrosidase and Microglia.

He most often published in these fields:

  • Neuroscience (50.91%)
  • Transplantation (26.11%)
  • Dopamine (26.89%)

What were the highlights of his more recent work (between 2009-2021)?

  • Neuroscience (50.91%)
  • Parkinson's disease (25.59%)
  • Dopaminergic (23.24%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Neuroscience, Parkinson's disease, Dopaminergic, Induced pluripotent stem cell and Dopamine. Ole Isacson has included themes like Embryonic stem cell, Amyotrophic lateral sclerosis and Neurodegeneration in his Neuroscience study. His work carried out in the field of Parkinson's disease brings together such families of science as Glucocerebrosidase and Central nervous system.

His Dopaminergic course of study focuses on Cell biology and Gene isoform. His studies in Induced pluripotent stem cell integrate themes in fields like Cancer research, In vitro, Cellular differentiation, Stem cell and Transplantation. Ole Isacson focuses mostly in the field of Dopamine, narrowing it down to matters related to Pharmacology and, in some cases, Agonist.

Between 2009 and 2021, his most popular works were:

  • Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats (389 citations)
  • Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease (367 citations)
  • Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease (367 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Neuron
  • Internal medicine

His scientific interests lie mostly in Neuroscience, Parkinson's disease, Neuron, Dopamine and Induced pluripotent stem cell. Ole Isacson is interested in Dopaminergic, which is a field of Neuroscience. His Parkinson's disease research incorporates themes from Oxidative stress, Endocrinology, Central nervous system, Enteric nervous system and Putamen.

His biological study deals with issues like Nervous system, which deal with fields such as Synapsin I, Tyrosine hydroxylase, Cell biology and Choline acetyltransferase. His study in Dopamine focuses on Substantia nigra in particular. The Induced pluripotent stem cell study combines topics in areas such as Cancer research, Cellular differentiation and LRRK2.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Parkinson’s Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors

Frank Soldner;Dirk Hockemeyer;Caroline Beard;Qing Gao.
Cell (2009)

1875 Citations

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

Marius Wernig;Jian Ping Zhao;Jan Pruszak;Eva Hedlund.
Proceedings of the National Academy of Sciences of the United States of America (2008)

1617 Citations

Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model

Lars M. Björklund;Rosario Sánchez-Pernaute;Sangmi Chung;Therese Andersson;Therese Andersson.
Proceedings of the National Academy of Sciences of the United States of America (2002)

1611 Citations

Specific MicroRNAs Modulate Embryonic Stem Cell–Derived Neurogenesis

Anna M. Krichevsky;Kai‐C. Sonntag;Ole Isacson;Kenneth S. Kosik.
Stem Cells (2006)

853 Citations

Altered Proteasomal Function in Sporadic Parkinson's Disease

Kevin St. P. McNaught;Roger Belizaire;Ole Isacson;Peter Jenner.
Experimental Neurology (2003)

784 Citations

Failure of the ubiquitin-proteasome system in Parkinson's disease.

Kevin St P. McNaught;Kevin St P. McNaught;C. Warren Olanow;Barry Halliwell;Ole Isacson.
Nature Reviews Neuroscience (2001)

681 Citations

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease

Terrence Deacon;James Schumacher;Jonathan Dinsmore;Christine Thomas.
Nature Medicine (1997)

566 Citations

Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats

Gunnar Hargus;Oliver Cooper;Michela Deleidi;Adam Levy.
Proceedings of the National Academy of Sciences of the United States of America (2010)

539 Citations

Dopamine neurons implanted into people with Parkinson’s disease survive without pathology for 14 years

Ivar Mendez;Angel Viñuela;Arnar Astradsson;Karim Mukhida.
Nature Medicine (2008)

506 Citations

Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

Oliver Cooper;Hyemyung Seo;Shaida Andrabi;Cristina Guardia-Laguarta.
Science Translational Medicine (2012)

492 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Ole Isacson

Stephen B. Dunnett

Stephen B. Dunnett

Cardiff University

Publications: 208

Anders Björklund

Anders Björklund

Lund University

Publications: 159

Roger A. Barker

Roger A. Barker

University of Cambridge

Publications: 100

Paul R. Sanberg

Paul R. Sanberg

University of South Florida

Publications: 95

Jeffrey H. Kordower

Jeffrey H. Kordower

Arizona State University

Publications: 91

Olle Lindvall

Olle Lindvall

Lund University

Publications: 81

Fred H. Gage

Fred H. Gage

Salk Institute for Biological Studies

Publications: 76

Marc Peschanski

Marc Peschanski

Grenoble Alpes University

Publications: 59

Cesario V. Borlongan

Cesario V. Borlongan

University of South Florida

Publications: 59

Patrik Brundin

Patrik Brundin

Van Andel Institute

Publications: 57

Anne Elizabeth Rosser

Anne Elizabeth Rosser

Cardiff University

Publications: 54

Lorenz Studer

Lorenz Studer

Kettering University

Publications: 54

C. Warren Olanow

C. Warren Olanow

Icahn School of Medicine at Mount Sinai

Publications: 51

Mahendra S. Rao

Mahendra S. Rao

National Institutes of Health

Publications: 49

Clive N. Svendsen

Clive N. Svendsen

Cedars-Sinai Medical Center

Publications: 48

Kwang-Soo Kim

Kwang-Soo Kim

Harvard University

Publications: 48

Trending Scientists

Bingbing Ni

Bingbing Ni

Shanghai Jiao Tong University

Heng Yin

Heng Yin

University of California, Riverside

Bo Wahlberg

Bo Wahlberg

Royal Institute of Technology

Wesley D. Allen

Wesley D. Allen

University of Georgia

James O. Sanders

James O. Sanders

Texas A&M University

Roger M. Gifford

Roger M. Gifford

Commonwealth Scientific and Industrial Research Organisation

Anthony P. J. Trinci

Anthony P. J. Trinci

University of Manchester

Xiangzheng Deng

Xiangzheng Deng

Chinese Academy of Sciences

Ludwig Haumaier

Ludwig Haumaier

University of Bayreuth

Guy Delrieu

Guy Delrieu

Grenoble Alpes University

Pascal Belin

Pascal Belin

Aix-Marseille University

Xavier Seron

Xavier Seron

Université Catholique de Louvain

Michael J. Kane

Michael J. Kane

University of North Carolina at Greensboro

Robert B. Cialdini

Robert B. Cialdini

Arizona State University

Aron S. Buchman

Aron S. Buchman

Rush University Medical Center

Something went wrong. Please try again later.